Importantly, APP processing is regulated by synaptic activity (Kamenetz et al., 2003; Cirrito et al., 2005) and one of the early neurochemical changes in AD is the dysfunction of cholinergic and glutamatergic synapses, which correlates with cognitive decline ante mortem (Selkoe, 2002). This evidence concerns the gene APP and Alzheimer disease.